Jacobs Levy Equity Management, Inc Vanda Pharmaceuticals Inc. Transaction History

Jacobs Levy Equity Management, Inc

$21.8 Billion
Q1 2024

A detailed history of Jacobs Levy Equity Management, Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,419,560 shares of VNDA stock, worth $7.25 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,419,560

Previous 1,429,850 0.72%

Holding current value

$7.25 Million

Previous $6.03 Million 3.3%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$3.47 - $4.61 $35,706 - $47,436	-10,290 Reduced 0.72%	1,419,560 $5.83 Million
Q4 2023 Feb 14, 2024	BUY	$3.38 - $4.58 $1.57 Million - $2.13 Million	463,994 Added 48.04%	1,429,850 $6.03 Million
Q3 2023 Nov 16, 2023	BUY	$4.28 - $6.57 $671,514 - $1.03 Million	156,896 Added 19.39%	965,856 $4.17 Million
Q2 2023 Aug 14, 2023	SELL	$5.9 - $6.95 $516,527 - $608,451	-87,547 Reduced 9.77%	808,960 $5.33 Million
Q1 2023 May 15, 2023	BUY	$6.18 - $7.99 $285,281 - $368,834	46,162 Added 5.43%	896,507 $6.09 Million

Q4 2022 Feb 14, 2023	SELL	$6.87 - $10.96 $38,643 - $61,650	-5,625 Reduced 0.66%	850,345 $6.28 Million
Q3 2022 Nov 15, 2022	SELL	$9.44 - $11.76 $1.66 Million - $2.06 Million	-175,525 Reduced 17.02%	855,970 $8.46 Million
Q2 2022 Aug 15, 2022	BUY	$9.31 - $11.84 $8.85 Million - $11.3 Million	950,812 Added 1178.45%	1,031,495 $11.2 Million
Q1 2022 May 16, 2022	BUY	$10.84 - $16.55 $874,603 - $1.34 Million	80,683 New	80,683 $913,000
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $1.37 Million - $1.85 Million	-87,493 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $2.06 Million - $2.85 Million	-134,141 Reduced 60.52%	87,493 $1.5 Million
Q2 2021 Aug 16, 2021	SELL	$15.71 - $21.51 $7.65 Million - $10.5 Million	-486,854 Reduced 68.72%	221,634 $4.77 Million
Q1 2021 May 17, 2021	SELL	$13.42 - $20.28 $576,402 - $871,046	-42,951 Reduced 5.72%	708,488 $10.6 Million
Q4 2020 Feb 16, 2021	BUY	$9.77 - $13.81 $2.96 Million - $4.19 Million	303,295 Added 67.68%	751,439 $9.87 Million
Q3 2020 Nov 16, 2020	BUY	$9.32 - $12.02 $4.18 Million - $5.39 Million	448,144 New	448,144 $4.33 Million
Q2 2019 Aug 13, 2019	SELL	$13.37 - $18.85 $172,473 - $243,165	-12,900 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$17.59 - $31.05 $1.49 Million - $2.63 Million	-84,635 Reduced 86.77%	12,900 $237,000
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $1.17 Million - $1.95 Million	61,910 Added 173.78%	97,535 $2.55 Million
Q3 2018 Nov 14, 2018	SELL	$18.25 - $23.0 $103,568 - $130,525	-5,675 Reduced 13.74%	35,625 $818,000
Q2 2018 Aug 14, 2018	BUY	$13.95 - $19.15 $89,419 - $122,751	6,410 Added 18.37%	41,300 $787,000
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $174,220 - $250,480	12,400 Added 55.14%	34,890 $588,000
Q4 2017 Feb 13, 2018	BUY	$12.85 - $18.1 $288,996 - $407,069	22,490	22,490 $342,000

Others Institutions Holding VNDA

# of Institutions

147

Shares Held

49.6M

Call Options Held

49.1K

Put Options Held

107K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $289M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account

Jacobs Levy Equity Management, Inc Vanda Pharmaceuticals Inc. Transaction History